MIST — Milestone Pharmaceuticals Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1408443 ·
Last close
$0.79
Market Cap
$98.10M
52W High
$3.06
52W Low
$0.75
ADV30
1,571,453
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 559,000 | 527,000 | -25,630,000 | -28,614,000 | 181,625,000 | 169,728,000 | 163,407,000 |
| Mar 2026 | 238,000 | 224,000 | -23,663,000 | -26,066,000 | 193,734,000 | 71,317,000 | 157,685,000 |
| Dec 2025 | 1,546,000 | — | -17,257,000 | -17,409,000 | 113,561,000 | 73,046,000 | 71,792,000 |
| Sep 2025 | 0 | — | -11,829,000 | -11,922,000 | 87,750,000 | 46,685,000 | 67,249,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-51,142,000
Investing CF
$-102,367,000
Financing CF
$179,741,000
CapEx
$-341,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.83
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-456,669,000
Inventory
$1,826,000
Receivables
$5,001,000
ST Investments
$112,899,000
EBIT TTM
$-61,325,000
Pretax Income TTM
$-68,363,000
Interest Exp TTM
$7,038,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,343,000
EBITDA
$-78,207,000
Free Cash Flow
$-41,687,376
Enterprise Value
$109,329,776
Total Cash
$170,608,992
Total Debt
$141,832,000
Shares Out
124,497,980
Trailing EPS
$-0.65
Book Value
$0.13
ROE
-35522.6%
ROA
-42.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,546,000 | -62,140,000 | -63,058,000 | 113,561,000 | 71,792,000 | 41,769,000 | -49,041,000 |
| Dec 2024 | 0 | -42,102,000 | -41,519,000 | 75,499,000 | 62,352,000 | 13,147,000 | -28,848,000 |
| Dec 2023 | 1,000,000 | -61,098,000 | -59,685,000 | 75,226,000 | 58,455,000 | 16,771,000 | -46,424,000 |
| Dec 2022 | 5,000,000 | -59,642,000 | -58,388,000 | 74,483,000 | 8,135,000 | 66,348,000 | -52,469,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.77
Max Pain — expiry 2026-12-18
max pain strike: $1.00 · spot: $0.80 · call oi: 3,677 · put oi: 526
Expected Move to 2026-12-18:
±$0.39
(48.72%) —
implied range
$0.41 –
$1.19
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HSTC | HST Global, Inc. | $99.00M | $0.70 | — |
| RFL | Rafael Holdings, Inc. | $99.35M | $1.94 | — |
| ANIX | Anixa Biosciences Inc | $96.64M | $2.78 | — |
| BMEA | Biomea Fusion, Inc. | $95.44M | $1.32 | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | $95.35M | $3.31 | — |
News headlines (Yahoo Finance, 1h cache)
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
2026-09-24 12:00 · Yahoo
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
2026-09-03 13:35 · Yahoo
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
2026-09-02 12:00 · Yahoo
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial
2026-08-21 13:28 · Yahoo
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
2026-08-21 12:00 · Yahoo
Milestone Pharmaceuticals Q2 Earnings Call Highlights
2026-08-12 15:04 · Yahoo
Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates
2026-08-12 12:25 · Yahoo
Milestone Pharmaceuticals shares tumble after Q2 earnings miss
2026-08-12 12:04 · Yahoo
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST)
2026-07-29 13:35 · Yahoo
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-03 01:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.